Key result
Targeted delivery of sh-SLIV RNA into mouse liver using Sendai virosomes selectively inhibited HCV-IRES-mediated translation and viral RNA replication.
Sendai virosomes can efficiently deliver shRNAs into liver tissue to block HCV replication in preclinical models.
May support targeted HCV inhibition via virosomes in mice; leaves open human translation and safety.
Internal ribosome entry site (IRES)-mediated translation of input viral RNA is the initial required step for the replication of the positive-stranded genome of hepatitis C virus (HCV). We have shown previously the importance of the GCAC sequence near the initiator AUG within the stem and loop IV (SLIV) region in mediating ribosome assembly on HCV RNA. Here, we demonstrate selective inhibition of HCV-IRES-mediated translation using short hairpin (sh)RNA targeting the same site within the HCV IRES. sh-SLIV showed significant inhibition of viral RNA replication in a human hepatocellular carcinoma (Huh7) cell line harbouring a HCV monocistronic replicon. More importantly, co-transfection of infectious HCV-H77s RNA and sh-SLIV in Huh7.5 cells successfully demonstrated a significant decrease in viral RNA in HCV cell culture. Additionally, we report, for the first time, the targeted delivery of sh-SLIV RNA into mice liver using Sendai virosomes and demonstrate selective inhibition of HCV-IRES-mediated translation. Results provide the proof of concept that Sendai virosomes could be used for the efficient delivery of shRNAs into liver tissue to block HCV replication.
No takes yet. Share an insight, caveat, or question.
Subramanian et al. (2009) studied Hepatitis C virus (HCV) infection. short hairpin (sh)RNA targeting the SLIV region of HCV IRES delivered via Sendai virosomes was evaluated on HCV-IRES-mediated translation and viral RNA replication. Targeted delivery of sh-SLIV RNA into mouse liver using Sendai virosomes selectively inhibited HCV-IRES-mediated translation and viral RNA replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: